# Claritas Rx Inc. — Form D

Claritas Rx Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-19. The offering totals $13.6M, of which $13.6M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2021-02-19
- Form: D
- Accession: 0001847010-21-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $13.6M
- Amount sold: $13.6M
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2021-02-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389958

## Issuer

- Name: Claritas Rx Inc.
- CIK: 0001847010
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 400 OYSTER POINT BLVD, SAN FRANCISCO, CA, 94080
- Phone: 415-689-7180

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Michael S Fitzgibbons | Director | South San Francisco, CA |
| Bradley S Sloan | Director | South San Francisco, CA |
| Mauricio S Buitrago | Executive Officer | South San Francisco, CA |
| Michael S Fitzgibbons | Executive Officer | South San Francisco, CA |
| Stuart S Kamin | Executive Officer | South San Francisco, CA |
| Nicholas S Krokoszynski | Executive Officer | South San Francisco, CA |
| Manoshi S Vasudevan | Executive Officer | South San Francisco, CA |

## More

- [CIK 1847010 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847010&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001847010-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.